luliconazole 10% solution (SKX-16)
/ Sato Pharma, Bausch Health
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 14, 2022
Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
(clinicaltrials.gov)
- P1 | N=20 | Active, not recruiting | Sponsor: SATO Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease
March 21, 2022
Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: SATO Pharmaceutical Co., Ltd. | Trial completion date: Feb 2022 ➔ Feb 2023 | Trial primary completion date: Dec 2021 ➔ Dec 2022
Trial completion date • Trial primary completion date • Infectious Disease
November 08, 2021
Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
(clinicaltrials.gov)
- P1; N=20; Recruiting; Sponsor: SATO Pharmaceutical Co., Ltd.
Clinical • New P1 trial • Infectious Disease
1 to 3
Of
3
Go to page
1